Concourse Financial Group Securities’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1495 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3363 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3357 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3404 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3413 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3358 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3354 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3337 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3288 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3234 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3023 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3090 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3044 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3205 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3177 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3098 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3040 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2983 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2840 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2746 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2801 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2749 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2448 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2827 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2804 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2677 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2232 |
|